Current Issue - May 2016
Health-linked incentives have become increasingly common, particularly by employers. But researchers are still trying to sort out what type and design of incentives are most effective and whether they hold significant potential to achieve both short- and long-term behavioral changes.
Depression's impact on health is often profound and far-reaching, potentially equaling that of coronary artery disease. To provide clinicians with guidance on treatment of depression, ACP has released a new clinical practice guideline that underscores the severe burden of depression and outlines viable treatment options for patients.
Latest Blog Posts
- Tips for clinician educators and aspiring clinicians
- Posted May 25 at 9:00 AM by Robert Centor, MD
- A doctor that every patient would want
- Posted May 24 at 9:00 AM by Suneel Dhand
- How bedside ultrasound was awesome last week
- Posted May 23 at 11:00 AM by Janice Boughton, MD, FACP
Environmental allergies are becoming more prevalent, and fortunately, so are treatments, as internists and allergists recommend options from changing the immediate environment to immunotherapy.
Much has been achieved in the past year, such as repealing the sustainable growth rate formula. New goals include advocating for further changes to Maintenance of Certification and helping physicians transition to new models of care delivery.
ACP has 4 concrete proposals to address rising prescription drug prices: regulating and negotiating prices, enhancing transparency, increasing competition, and considering value.
This issue covers topics such as offering incentives to help patients change their lifestyles, treating depression and its extensive influence on overall health, and new modalities for treating allergies.
Prior authorization related to medications or referrals to specialty care or testing drain physician and staff time on burdensome administrative tasks instead of patient care. Practices can try some tips to mitigate some of the burdens.
This update covers approval of Crizotinib (Xalkori) to treat people with metastatic non-small-cell lung cancer whose tumors have an ROS-1 gene alteration.
A 62-year-old woman is evaluated for a 4-month history of decreased exercise tolerance, joint stiffness, mild weakness, and a rash on her hands. She has noted increasing difficulty carrying heavy objects and feels exhausted after climbing stairs. Although her joints are stiff, she has not had any joint swelling. Her rash developed around the time of her other symptoms and has not responded to over-the-counter topical agents. She has no other symptoms, including cough or dyspnea. Medical history is unremarkable, and she takes no medications. Follow a physical exam, cardiopulmonary exam, and lab studies, which of the following pulmonary conditions is associated with this patient's clinical presentation?
ACP Internist Weekly
From the May 24, 2016 edition
- Lower systolic blood pressure target appears to improve outcomes in elderly patients without diabetes or stroke
- Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction
If you enjoy ACP Internist, sign up for ACP InternistWeekly, an electronic newsletter that covers the latest news in medicine. Click here to subscribe.
Join ACP Internist on Twitter
Get updates automatically and connect with members and other doctors by following ACP Internist's Twitter feed.
CME Bulletin Board
Find continuing medical education events for physicians.